Biotech

BioNTech and Vir prepare mega-IPOs after flurry of launches

https://pharmaphorum.com/news/biontech-and-vir-prepare-mega-ipos-after-flurry-of-launches/

J+D Forecasting bring their Face-to-Face Pharma training to Boston in October 2019

https://pharmaphorum.com/events/jd-forecasting-bring-their-face-to-face-pharma-training-to-boston-in-october-2019/

J+D Forecasting bring their Oncology Forecasting Training to Boston in October

https://pharmaphorum.com/events/jd-forecasting-bring-their-oncology-forecasting-training-to-boston-in-october/

Orchard to file gene therapy in life-threatening rare disease next year

https://pharmaphorum.com/news/orchard-to-file-gene-therapy-in-life-threatening-rare-disease-next-year/

Advancing the Next Generation of Microbiome-Based Therapeutics in Asia

https://pharmaphorum.com/events/advancing-the-next-generation-of-microbiome-based-therapeutics-in-asia/

4 Reasons Why Asia is the Next Hub of Microbiome Innovation

https://pharmaphorum.com/partner-content/4-reasons-why-asia-is-the-next-hub-of-microbiome-innovation/

As cancer treatments evolve, so must investment mechanisms

https://pharmaphorum.com/views-analysis-oncology/as-cancer-treatments-evolve-so-must-investment-mechanisms/

Woodford’s woes could cause biotech fire-sale

https://pharmaphorum.com/news/woodfords-woes-could-cause-biotech-fire-sale/

Flipping the paradigm – how should biotechs harness adaptive trials?

https://pharmaphorum.com/r-d/views-analysis-r-d/flipping-the-paradigm-how-should-biotechs-harness-adaptive-trials/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search